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Primate lentiviruses, including HIV-1, transduce
terminally differentiated, nondividing myeloid cells;
however, these cells are refractory to infection by
gammaretroviruses such as murine leukemia virus
(MLV). Here, we present evidence that a cellular
restriction is the obstacle to transduction of macro-
phages by MLV. Neutralization of the restriction by
Vpx, a primate lentiviral protein previously shown to
protect primate lentiviruses from a macrophage
restriction, rendered macrophages permissive to
MLV infection. We further demonstrate that this
restriction prevents transduction of quiescent mono-
cytes by HIV-1. Monocyte-HeLa heterokaryons were
resistant to HIV-1 infection, while heterokaryons
formed between monocytes and HeLa cells express-
ing Vpx were permissive to HIV-1 infection. Encapsi-
dation of VpxwithinHIV-1 virions conferred the ability
to infect quiescent monocytes. Collectively, our
results indicate that the relative ability of lentiviruses
and gammaretroviruses to transduce nondividing
myeloid cells is dependent upon their ability to
neutralize a cellular restriction.
INTRODUCTION
A fundamental characteristic that distinguishes lentiviruses from
simple gammaretroviruses is their capacity to infect nondividing
cells (reviewed in Suzuki and Craigie, 2007; Yamashita and
Emerman, 2006). Primate lentiviruses such as HIV-1 are able to
transduce nondividing cells (Bukrinsky et al., 1992; Lewis et al.,
1992), and this underscores their ability to transduce terminally
differentiated nondividing cells, including macrophages, micro-
glia, and dendritic cells, both in vitro and in vivo (Gartner et al.,
1986; Ringler et al., 1989; Weinberg et al., 1991). In contrast,
gammaretroviruses transduce cells in mitosis, and nondividing
cells (in G1/S/G2 phase) are refractory to gammaretrovirus trans-
duction (Bieniasz et al., 1995; Lewis et al., 1992; Lewis and Emer-
man, 1994; Roe et al., 1993). Furthermore, although lentiviruses
have evolved the ability to infect terminally differentiated nonpro-
liferating cells, quiescent cells (G0) are refractory to lentivirus
transduction. This is best exemplified by observations made68 Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc.with myeloid-lineage cells. Studies conducted with HIV-1
demonstrate that peripheral blood monocytes, which are the
undifferentiated precursors to tissue macrophages, are highly
refractory to infection (Collman et al., 1989; Di Marzio et al.,
1998; Eisert et al., 2001; Naif et al., 1998; Neil et al., 2001; Rich
et al., 1992; Sonza et al., 1996). Permissivity to HIV-1 infection
is coordinated to the state of monocyte differentiation (Sonza
et al., 1996; Triques and Stevenson, 2004).
The mechanisms underscoring the differential ability of gam-
maretroviruses and lentiviruses to transduce nondividing
myeloid cells as well as the block to transduction of quiescent
monocytes by lentiviruses are not well understood. Cell trans-
duction by gammaretroviruses and lentiviruses requires
synthesis of viral cDNA and translocation of viral cDNA to the
nucleus in order for viral cDNA to integrate into cellular DNA.
Synthesis of viral cDNA and transport of viral cDNA to the cell
nucleus occurs within the context of a large (160 s) ribonucleo-
protein reverse transcription/preintegration complex, which
contains viral reverse transcriptase as well as the viral integrase
that catalyzes formation of the integrated provirus (Bowerman
et al., 1989). Therefore, transduction of a nondividing cell
requires translocation of this complex across the nuclear enve-
lope in order for viral cDNA to contact chromatin. One possible
explanation for the differential ability of lentiviruses and gammar-
etroviruses to transduce nondividing cells is that reverse tran-
scription complexes of lentiviruses harbor nucleophilic determi-
nants that direct their nuclear translocation, whereas reverse
transcription complexes of gammaretroviruses lack these deter-
minants (reviewed in Suzuki and Craigie, 2007; Yamashita and
Emerman, 2006).
A different set of factors has been proposed to regulate infec-
tion of quiescent monocytes by lentiviruses. G0 monocytes have
low intracellular dNTP levels (O’Brien et al., 1994; Triques and
Stevenson, 2004), and this has been proposed to limit the
efficiency of viral cDNA synthesis in these quiescent cells. The
cytidine deaminase APOBEC3G, which is a target of the viral
accessoryprotein Vif, hasbeen shown to influence thepermissiv-
ity of quiescent lymphocytes and monocytes to HIV-1 infection
(Chiu et al., 2005; Ellery et al., 2007; Peng et al., 2006, 2007).
APOBEC3G is sequestered in an enzymatically active low-
molecular-mass (LMM) ribonucleoprotein complex or in an enzy-
matically inactive high-molecular-mass (HMM) complex. The
LMM complex, which is the exclusive form in quiescent cells,
has been shown to restrict infection of quiescent monocytes by
HIV-1 (Chiu et al., 2005; Ellery et al., 2007; Peng et al., 2006).
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Cellular Restriction and Myeloid Cell TransductionFigure 1. MLV Infection of Macrophages Is Blocked at or Prior to Reverse Transcription of Viral cDNA
(A and B) Terminally differentiatedmacrophages and HeLa cells were infected withMLV and HIV-1 variants expressing GFP at different levels of input virions. The
frequency of GFP+ cells (A) and viral cDNA copies (B) was determined 48 hr postinfection.
(C) MLV infection of aphidicolin-treated and untreated HeLa cells. Viral cDNA (upper two panels) and viral integrants (lower panel) were determined at different
levels of input virus based on tissue culture infectious dose50 (TCID50), where one TCID50 is the amount of virus inoculum that yielded 50% transduction on HeLa
cells. Error bars are SD of replicate samples from three independent experiments done on HeLa cells or macrophages from different donors.A number of studies have suggested that the accessory
proteins Vpr and Vpx of primate lentiviruses have evolved to
specifically promote infection of nondividing myeloid-lineage
cells (Balliet et al., 1994; Connor et al., 1995; Fletcher et al.,
1996; Goujon et al., 2008; Heinzinger et al., 1994; Sharova
et al., 2008; Srivastava et al., 2008). By generating heterokaryons
between cells in which Vpx was dispensable for infection and
primary macrophages in which Vpx is required for SIV infection,
we demonstrated that macrophages harbor a dominant restric-
tion and that this restriction is specifically counteracted by Vpx
(Sharova et al., 2008). In the current study, we demonstrate
that this restriction is an obstacle to transduction of terminally
differentiated nondividing cells by gammaretroviruses. Further-
more, we present evidence that the ability of lentiviruses to trans-
duce quiescent monocytes is regulated by this same restriction
and that neutralization of the restriction in monocytes confers
susceptibility to lentivirus infection. Collectively, our results
suggest that the relative ability of lentiviruses and gammaretrovi-
ruses to transduce nondividing myeloid cells is governed
primarily by their ability to neutralize a restriction that is present
within these cells.
RESULTS
A Dominant Restriction Limits MLV Infection
of Macrophages
Themajority of studies that have examined obstacles to infection
of nondividing cells by gammaretroviruses have been conductedwith artificially growth-arrested cell lines. Whether similar blocks
exist in natural nondividing cells such as macrophages has not
been fully examined. In order to gain further insight into the
mechanism underlying the block to macrophage transduction
by MLV, we compared the extent of viral cDNA synthesis and
the efficiency of viral transduction in primary macrophages.
Transduction efficiency of HIV-1 and MLV in primary macro-
phages was assessed relative to transduction efficiencies in
HeLa cells, which are permissive to both HIV-1 and MLV trans-
duction. Macrophages were transduced by HIV-1 at a level
comparable to that observed in HeLa cells, as evidenced by
the frequency of GFP+ cells (Figure 1A) and levels of viral
cDNA synthesis (Figure 1B). In contrast, transduction of macro-
phages byMLVwas highly inefficient (Figures 1A and 1B). There-
fore, the primary block to transduction of macrophages by MLV
appeared to be at the level of reverse transcription. In agreement
with a previous study (Jarrosson-Wuilleme et al., 2006), we
observed a low level of transduction (2%–3% GFP+) of primary
macrophages by MLV. While artificially growth-arrested HeLa
cells are refractory to transduction byMLV (Lewis and Emerman,
1994; Roe et al., 1993), the block to infection of those cells by
MLV was unrelated to the reverse transcription block in termi-
nally differentiated macrophages (Figure 1C). Levels of MLV
cDNA in aphidicolin-treated HeLa cells were comparable to
those in untreated HeLa cells, and nuclear localization of viral
cDNA (as indicated by 2-LTR circles that are formed in the
nucleus) was also comparable. However, integration of MLV
cDNA was inefficient in aphidicolin-treated HeLa cellsCell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc. 69
Cell Host & Microbe
Cellular Restriction and Myeloid Cell TransductionFigure 2. A Restriction Prevents Transduction of Macrophages by MLV
(A) Heterokaryons were formed between primary macrophages and HeLa cells expressing fusogenic HN and F proteins of Newcastle disease virus (NDV). HeLa
cells were stained with DiO (green), and macrophages were stained with DiD (red). Double-stained heterokaryons were sorted by FACS as indicated by the gate
(A). FACS profile of heterokaryons postsorting (fused postsort) is shown (middle panel) as are representative double-staining heterokaryons presort and postsort
(right panels). Because of the lipophilic nature of DiO and DiD, fluorescence concentrates in lipid-rich regions in the center of the cell rather than being evenly
distributed throughout the cell. Susceptibility of HeLa-macrophage (HeLa-mac) heterokaryons to MLV infection was compared with infection levels in HeLa
and in macrophages. Infection was gauged from the levels of late MLV cDNAs and 2-LTR circle cDNAs. Values were expressed relative to those obtained for
HeLa cells (error bars are SD from three independent experiments).
(B) Susceptibility of HeLa-macrophage heterokaryons to MLV infection was examined after expression of Vpx in HeLa cells. Double-stained cells were sorted by
FACS as indicated by the gate. MLV infection in HeLa-macrophage heterokaryons and heterokaryons formed between macrophages and Vpx-expressing HeLa
cells (HeLa-Vpx-mac) were gauged as outlined in (A) (error bars are SD of three independent experiments).
(C) MLV infection of aphidicolin-treated (+Aph) and untreated (Aph) HeLa cells transfectedwith a Vpx expression vector (pCDH-Vpx) or an empty vector (pCDH).
Error bars are SD of replicate samples from two independent experiments done on HeLa cells.(Figure 1C). Therefore, the block that was observed in an artifi-
cially growth-arrested cell line was distinct from the block that
occurs in natural nondividing targets of lentivirus infection.
We have previously presented evidence that macrophages
harbor a restriction that antagonizes HIV-1, HIV-2, and SIV at
the level of reverse transcription and that the Vpx protein of
HIV-2/SIVsmm specifically overcomes this restriction (Sharova
et al., 2008). We investigated whether the restriction that antago-
nizes lentivirus infection of macrophagesmay also be preventing
infection of macrophages by MLV. We used a heterokaryon70 Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc.strategy that we previously adopted to demonstrate that Vpx
countered a dominant restriction that was specifically expressed
inmacrophages (Sharovaet al., 2008). SinceHeLacells are highly
permissive to MLV infection, heterokaryons were generated
between macrophages and HeLa cells, and the susceptibility of
the heterokaryons to MLV infection was assessed. When the
fusogenic proteins of Newcastle disease virus (NDV) were ex-
pressed in HeLa cells, these cells readily fused with primary
macrophages (Figure 2A). HeLa-macrophage heterokaryons
(double-stained cells, as indicated by the gate) were then sorted
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karyons is shown (Figure 2A, middle panel). Representative
images of double-staining heterokaryons are shown (Figure 2A,
right panels). Presort images show one double-staining hetero-
karyon and two adjacent nonfused cells (DiO stained only), and
one heterokaryon postsort is shown. Because of the lipophilic
nature of the dyes, fluorescence concentrates in lipid-rich
regions of the cell. The block to MLV infection of macrophages
was at the level of reverse transcription (Figure 1). Therefore,
the ability of MLV to infect HeLa-macrophage heterokaryons
was gauged by the relative levels of late MLV cDNA transcripts
and 2-LTR circles, which are formed only after completion of viral
reverse transcription. While HeLa cells were permissive to MLV
infection, macrophages and HeLa-macrophage heterokaryons
were not permissive to MLV infection (Figure 2A). We next exam-
ined the ability of Vpx to overcome the block to MLV infection of
HeLa-macrophage heterokaryons. When Vpx was expressed in
HeLa cells and those cells were allowed to fuse with macro-
phages, the resulting heterokaryons were rendered permissive
to MLV infection (Figure 2B, right panels). In contrast, HeLa-
macrophage heterokaryons not expressing Vpx remained refrac-
tory to MLV infection (Figure 2B). The expression of Vpx in HeLa
cells did not increase their susceptibility to MLV infection
(Figure 2C). Furthermore, the block imparted by aphidicolin treat-
ment of HeLa cells was not released when Vpx was expressed in
those cells (Figure 2C). Collectively, these data indicate that
nondividing macrophages harbor a dominant restriction that
prevents MLV infection, and Vpx overcomes the restriction.
Furthermore, the block toMLV infection of nondividingHeLa cells
is distinct from that observed in macrophages and is not over-
come by Vpx.
Neutralization of the Macrophage Restriction Confers
Permissivity to MLV Infection
We next examined whether neutralization of the restriction by
Vpx would be sufficient to render macrophages permissive to
MLV. We first examined whether introduction of Vpx into macro-
phages by wild-type SIV (SIVWT) infection would render those
macrophages susceptible to subsequent transduction by MLV.
Infection of primarymacrophages with increasing levels of SIVWT
(PBj) led to a dose-dependent increase in the level of MLV trans-
duction based on MLV cDNA synthesis (Figure 3A). Preinfection
ofmacrophages with a SIVWT but not a Vpx-deleted SIV (SIVDVpx)
also resulted in an increased ability of MLV to transduce macro-
phages, as evidenced by MLV cDNA synthesis (Figures 3B and
3C) and expression of GFP from the MLV genome (Figure 3D).
We have previously demonstrated that the restriction to infection
of macrophages by lentiviruses can be overcome by Vpx from
SIVPBj and HIV-2 but not Vpr of HIV-1 (Sharova et al., 2008).
While Vpx alleles from SIVPBj and SIVmac239 enhanced infection
of macrophages by MLV, no significant effect was observed
with SIVagm Vpr (Figure 3C). Vpx also appeared to neutralize
the restriction in cells in which it was expressed, since MLV
transduction occurred predominantly in macrophages that had
also been transduced by SIV (GFP expression, Figure 3E). We
did not observe dsRed+/GFP+ cells in macrophages infected
only with SIV (Figure 3E). Therefore, the presence of double-
positive cells was not simply due to bleeding of the GFP signal
into the dsRed channel.Packaging of Vpx within MLV Virions Confers
a Lentiviral Phenotype
During lentivirus infection of macrophages, the restriction is
neutralized by Vpx proteins that are encapsidated within the
virus particle (Sharova et al., 2008). Therefore, we examined
whether packaging of Vpx within MLV virions would be sufficient
to confer upon MLV a lentiviral phenotype, i.e., the ability to
transduce macrophages. The p6 domain of lentiviral gag
proteins contains determinants for encapsidation of Vpr/Vpx
proteins (Accola et al., 1999; Pancio and Ratner, 1998; Paxton
et al., 1993; Wu et al., 1994). We fused the p6 domain of SIV
gag to the C terminus of the MLV gag protein (Figure 4A). Trans-
fection of an MLV packaging cell line with plasmids expressing
chimeric MLV gag-SIV p6 proteins, a Vpx expression vector,
and a VSV-G envelope-expression vector resulted in the produc-
tion of VSV-G-pseudotyped chimeric MLV virions containing
Vpx. The presence of the VSV-G envelope bypassed the require-
ment for the presence of MLV receptor molecules on macro-
phages. Specific packaging of Vpx into MLV particles containing
a chimeric gag p6 domain was confirmed by western blotting
(Figure 4B). In contrast, MLV virions derived from a Vpx-express-
ing MLV packaging line containing wild-type MLV gag (lacking
SIV p6) did not package Vpx proteins (Figure 4B).
We next examined the functionality of the p6 domain within the
chimeric MLV gag protein by its ability to package a b-lacta-
mase-Vpr fusion protein within virions (Cavrois et al., 2002).
Transfer of the b-lactamase-Vpr fusion protein into HeLa cells
was then detected by enzymatic cleavage of CCF2, which is a
fluorescent substrate of b-lactamase. Infection of CCF2-loaded
HeLa cells by chimeric MLV harboring a b-lactamase-Vpr fusion
protein resulted in CCF2 cleavage, as evidenced by the appear-
ance of blue cells under fluorescence microscopy (Figure 4B).
This was not the case for CCF2-loaded HeLa cells that had
been infected with MLV harboring a wild-type gag protein (Fig-
ure 4B). Packaging of VpxwithinMLV virions containing chimeric
gag proteins markedly increased their ability to transduce
primary macrophages, both in terms of viral cDNA synthesis
and integration (Figures 4C and 4D) and in terms of red fluores-
cent protein expression from the MLV genome (Figures 4E and
4F). The chimeric MLV variant containing the SIV gag p6 domain
required Vpx for infection of macrophages since, in the absence
of Vpx, this chimeric MLV did not transduce macrophages
(Figure 4D). Furthermore, MLV cDNA that was detected in these
macrophages was synthesized de novo and was inhibited in the
presence of AZT (Figure 4D). Transduction efficiencies of
chimeric MLV particles containing Vpx (15% at high moi)
approached those typically observed for lentivirus-based
vectors (Figure 4F, upper panel). The transduction efficiency of
MLV with or without packaged Vpx was similar when gauged
on HeLa cells (Figure 4F, lower panel). Collectively, these results
indicate that Vpx is sufficient to render primary macrophages
permissive to MLV infection and that a restriction is the obstacle
to MLV transduction of nondividing macrophages.
The Resistance of Quiescent Monocytes to Lentivirus
Transduction Is Governed by a Restriction
Circulating peripheral blood monocytes are highly refractory
to lentivirus infection in vitro, and infection is blocked at an
early postentry step (Collman et al., 1989; Naif et al., 1998;Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc. 71
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Cellular Restriction and Myeloid Cell TransductionFigure 3. Vpx Permits Transduction of Macrophages by MLV In trans
(A) Vpx delivered to macrophages by wild-type SIV (SIVWT) infection removes the block to synthesis of MLV cDNA in macrophages. Macrophages were initially
infected with increasing titers of SIVWT and subsequently infected with MLV (four TCID50) after 4 hr. Synthesis of MLV cDNA was assessed 48 hr after MLV
infection.
(B–D) Vpx but not Vpr is necessary for the ability of SIV to remove the block tomacrophage transduction byMLV.Macrophages were infected by SIVWT or SIVDVpx
and subsequently infected byMLV-GFP (four TCID50) after 4 hr. The frequency of GFP and viral cDNA copies was determined 48 hr postinfection (B). Error bars in
(A) and (B) are SD of replicate samples from three independent experiments done on macrophages from different donors.
(C) Macrophageswere infectedwith the indicated SIV infectious clones and thenwithMLVdsRed. The efficiency ofMLV transduction was assessed 48 hr after MLV
infection.
(D) A representative field of macrophages transduced by MLV-GFP.
(E) Transduction of macrophages by MLV occurs primarily in SIV-infected macrophages. SIVGFP-infected macrophages were transduced with MLVdsRed, and
frequencies of coinfected cells were evaluated by FACS. FACS profiles of uninfected macrophages, MLV-transduced macrophages without prior SIV infection
(MLV alone), or SIVWT without subsequent MLV infection (SIVWT alone) served as controls.Neil et al., 2001; Rich et al., 1992; Sonza et al., 1996; Triques and
Stevenson, 2004). Susceptibility to infection occurs only upon
differentiation of monocytes to macrophages (Mu¨nk et al.,
2002; Sonza et al., 1996; Triques and Stevenson, 2004). We first
investigated whether the fusion of HeLa cells with monocytes
would result in heterokaryons permissive to HIV-1 infection. To
generate HeLa-monocyte heterokaryons, we exploited the fuso-
genic properties of Sendai virus (hemagglutinating virus of Japan
[HVJ]) envelope proteins. The susceptibility of those hetero-
karyons to HIV-1 and to SIV infection was then examined. SIV
infection was gauged from the level of late cDNAs, and HIV-172 Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc.infection was determined by luciferase activity expressed from
the HIV-1 genome (values were expressed as percentages of
those obtained with HeLa cells). As with unfused monocytes,
HeLa-monocyte heterokaryons were highly refractory to trans-
duction by HIV-1 (Figure 5A). It has previously been demon-
strated that Vpx increases monocyte infection by SIV (Wolfrum
et al., 2007). In agreement, we observed that both primarymono-
cytes and HeLa-monocyte heterokaryons were permissive to
transduction by SIV (Figure 5A). To examine whether the ability
of SIV to transduce primary monocytes was attributable to
Vpx, we generated heterokaryons between monocytes and
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Cellular Restriction and Myeloid Cell TransductionFigure 4. MLV Virions Encapsidating Vpx Exhibit a Lentiviral Phenotype
(A) A schematic of vectors used for expression of Vpx and chimeric MLV gag proteins containing the p6 domain of SIV gag, which harbors the Vpx/Vpr packaging
determinant.
(B) Packaging of Vpx within MLV virions harboring an SIV gag p6 domain. Upper panel: packaging of Vpx within MLV virions containing or lacking an SIV gag p6
domain was examined by western blotting with a Vpx-specific antibody. Lower panels: b-lactamase-Vpx fusion proteins were packaged in MLV variants con-
taining or lacking the SIV gag p6 domain, and b-lactamase activity was examined following infection of HeLa cells loaded with the b-lactamase substrate CCF2.
(C) Packaging of Vpx within chimeric MLV virions containing SIV gag p6 (MLVp6) removes a block to reverse transcription in macrophages. Macrophages were
infected with increasing concentrations of MLVp6 with or without encapsidated Vpx, and viral cDNA synthesis (late cDNA, upper panel) and integration (lower
panel) was assessed.
(D–F) A p6 encapsidation signal and Vpx are required for MLV transduction of macrophages. MLV cDNA synthesis (D) was examined after infection of macro-
phageswithMLV andMLVp6 variants with andwithout Vpx. Infections carried out in the presence of AZT verified de novo synthesis ofMLV cDNA. Error bars in (C)
and (D) are SD of replicate samples from three independent experiments done onmacrophages from different donors (E). Packaging of Vpx permits transduction
of primary macrophages by MLV. Macrophages were infected with increasing titers of chimeric MLV variants with and without Vpx as in (C). Transduction was
gauged by expression of dsRed from the MLV transgene. Frequencies of MLV transduction (dsRed expression) on macrophages (upper panel) and HeLa (lower
panel) are indicated in (F). Error bars are SD of replicate samples from three independent experiments done on macrophages or HeLa cells.between HeLa cells that expressed the Vpx protein (Figure 5B).
In this case, the permissivity of HeLa-monocyte heterokaryons
toHIV-1 transduction was increased by Vpx (Figure 5B), whereas
HeLa-monocyte heterokaryons not expressing Vpx remainedrefractory to HIV-1 transduction (Figure 5B). Since Vpx does
not increase the efficiency of HIV-1 infection in HeLa cells, this
result was not due to infection of unfused HeLa cells. Therefore,
we conclude that heterokaryons formed between nonpermissiveCell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc. 73
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Cellular Restriction and Myeloid Cell TransductionFigure 5. Transduction of Primary Monocytes by HIV-1 Is Blocked by a Restriction
(A) Heterokaryons were formed between primary monocytes and HeLa cells using HVJ Envelope Cell Fusion kit (see Experimental Procedures). FACS analysis of
HeLa-monocyte heterokaryons (left panels) is shown. HeLa cells expressed GFP, and macrophages were stained with an APC-conjugated antibody to CD14.
Double-stained cells were sorted as indicated by the gate. SIV infection was gauged from the levels of late cDNA, and HIV-1 infection was gauged from luciferase
activity (right panels). Values were expressed relative to those obtained for HeLa cells. Error bars are SD of four independent experiments.
(B) Vpx renders HeLa-monocyte heterokaryons permissive to HIV-1 infection. Heterokaryons were formed between primary monocytes and HeLa cells express-
ing Vpx as described in (A). Susceptibility of HeLa-monocyte heterokaryons to HIV-1 infection was examined after expression of Vpx in HeLa cells. FACS analysis
of HeLa-Vpx-monocyte heterokaryons is shown in the left panels. Double-stained cells were sorted as indicated by the gate. Infection of monocytes and infection
of HeLa-monocyte heterokaryons with and without Vpx was gauged by luciferase activity. Error bars are SD from two independent experiments.monocytes and permissive HeLa cells are nonpermissive, due to
the presence of a dominant restriction, and that this restriction is
overcome by Vpx. We titered the amount of Vpx needed to
rescue SIVDVpx infection in macrophages and observed that
even a small amount of trans-packaged Vpx can counter the
restriction present in macrophages (Figure S1). Vpx is packaged
in molar amounts equivalent to gag proteins (Henderson et al.,
1988). Assuming 2000 gag molecules per virion (Arthur et al.,
1992) and assuming uniform Vpx:gag stoichiometry in each viral
particle, Vpx packaged at 10% of wild-type levels still rescued
a DVpx virus (Figure S1), suggesting that as few as 20 Vpx mole-
cules can counteract the restriction.
Vpx Renders Primary Monocytes Permissive
to HIV-1 Transduction
Since Vpx was sufficient to render HeLa-monocyte hetero-
karyons permissive to HIV-1 infection (Figure 5), we next exam-
inedwhether Vpxwas sufficient to rendermonocytes susceptible
to HIV-1 transduction. Since monocytes were partially permis-
sive to SIVWT transduction (Figure 5A), Vpx was introduced into
monocytes by SIVWT infection, and those monocytes were
subsequently examined for permissivity to HIV-1. SIV infection
rendered monocytes highly permissive to subsequent HIV-1
infection, as evidenced by an increase in HIV-1 cDNA synthesis
(Figure 6A). In contrast, monocytes that had not been preinfected
with SIV remained refractory to HIV-1 (Figure 6A). Furthermore,
monocytes infected with SIVWT but not SIVDVpx could be trans-
duced by HIV-1, as evidenced by expression of GFP from the
HIV-1 genome (Figures 6B and 6C). Similarly, packaging of Vpx
within HIV-1 virions (Figure 6D) or in an HIV-1 lentivirus vector74 Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc.(pCDH-Vpx) (Figure 6E) markedly increased the efficiency of
transduction in primary monocytes. We also examined whether
the impact of the restriction was reversible. We speculated
that, following infection of macrophages by a SIVDVpx virus, we
might be able to rescue the infection by subsequent introduction
of Vpx. At various intervals following infection by a SIVDVpx virus
(containing a GFP transgene), cells were superinfected by SIVWT
or SIVDVpx variants. The ability to rescue the initial SIVDVpx infec-
tion was gauged by PCR using primers specific for GFP. We
observed that SIVDVpx GFP reverse transcription could be
restored at least 5 hr later by a wild-type virus (Figure S2). Since
this is in the time frame required for uncoating to occur, it
suggests that the restriction might act subsequent to uncoating.
Vpx Affects Monocyte Permissivity Independent
of APOBEC3G or Differentiation Status
To investigate the possibility that Vpx rendered monocytes
permissive to infection by causing a shift in APOBEC3G from
LMM to HMM complexes, we compared the distribution of
APOBEC3G in uninfected monocytes and in monocytes infected
with SIVWT and SIVDVpx. As published previously (Chiu et al.,
2005), APOBEC3G was sequestered primarily in an HMM
complex in H9 cells and in differentiated (day 10) macrophages
(Figure 7A). RNase treatment of HMM complexes from H9 cells
led to the formation of LMM APOBEC3G complexes (Figure 7A).
In undifferentiated (day 0) monocytes, APOBEC3G was seques-
tered primarily in an LMM complex (Figure 7A). Infection of
monocytes by SIVWT or SIVDVpx did not noticeably alter distribu-
tion of APOBEC3G between LMM and HMM complexes
(Figure 7A).
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Cellular Restriction and Myeloid Cell TransductionFigure 6. Vpx Counteracts a Monocyte Restriction to HIV-1 Infection In trans
(A) Infection of monocytes by SIVWT removes a reverse transcription block to subsequent infection by HIV-1. SIVWT-infected monocytes were subsequently
infected (4 hr later) by HIV-1 on the indicated intervals, and levels of HIV-1 cDNA synthesis were gauged 48 hr after HIV-1 infection.
(B) Prior infection by SIVWT but not SIVDVpx renders primary monocytes permissive to subsequent transduction by HIV-1. Monocytes were infected as in (A).
Transduction of HIV-1 (based on GFP expression) was assessed 72 hr after HIV-1 infection.
(C) Representative fields of primary monocytes following transduction by HIV-1-GFP.
(D) HIV-1 virions encapsidating Vpx efficiently transduce primary monocytes. Monocytes were infected with HIV-1-GFP variants in which Vpx was packaged.
Levels of transduction (percent of GFP+ monocytes) were determined at the indicated intervals after monocyte infection.
(E) Transduction ofmonocytes with anHIV-1 lentivirus vector in which Vpxwas or was not packaged.Monocytes were infected at the indicated intervals, andGFP
expression was examined 72 hr postinfection. Error bars in (A), (B), and (E) are SD of replicate samples from three independent experiments done on monocytes
from different donors.It was possible that HIV-1 transduction was restricted to
a small percentage of differentiated (CD71+) macrophages in
the culture. To examine this, frequencies of infected monocytes
(CD71) and macrophages (CD71+) were examined by FACS
following infection with a GFP-expressing HIV-1 variant in which
Vpx had been packaged. Infection of monocytes by HIV-1 either
with or without Vpx did not have an effect on temporal expres-
sion of CD71 (Figure 7B). In addition, as the frequency of GFP+
cells increased, there was no apparent bias to an increased
frequency of CD71+/GFP+cells (Figure 7C). Indeed, the frequen-
cies of infected CD71monocytes at days 2, 3, and 4 postinfec-
tion paralleled those for infected CD71+ cells (Figure 7C). In an
independent experiment (Figure 7D), equivalent transduction of
CD71+ and CD71 by HIV-1 over 6 days postinfection wasmain-tained. Collectively, these results indicate that Vpx directly
renders undifferentiated monocytes permissive to HIV-1 trans-
duction without inducing their differentiation.
DISCUSSION
Our studies indicate that a cellular restriction is the obstacle to
transduction of terminally differentiated macrophages by MLV
and that when the restriction is neutralized by the primate lenti-
viral Vpx protein, macrophages become permissive to MLV.
Current models, based primarily on studies with artificially
growth-arrested fibroblast cell lines, suggest that the relative
abilities of gammaretroviruses and lentiviruses to traverse the
nuclear envelope dictate the differential abilities of these virusesCell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc. 75
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Cellular Restriction and Myeloid Cell TransductionFigure 7. Vpx Renders Monocytes Permissive to HIV-1 Infection without Inducing Monocyte Differentiation or APOBEC3G Distribution
(A) Distribution of APOBEC3G between LMM and HMM nucleoprotein complexes in undifferentiated (d0) monocytes, differentiated (d10) macrophages, and
SIV-infectedmonocytes. Distribution of APOBEC3GbetweenH9 cell-derivedHMMand LMMcomplexes before and after RNase treatment is shown for comparison.
(B) Vpx does not affect differentiation status of monocytes in culture. Fresh monocytes were infected with HIV-1DVprGFP that had or had not packaged Vpx, and
the infection levels in monocyte/macrophage (CD14+) and differentiated monocyte (CD71+) subsets was determined by FACS at the indicated intervals post-
infection.
(C and D) HIV-1 with encapsidated Vpx equally transduces undifferentiated (CD71) and differentiated (CD71+) monocyte populations. Monocytes were infected
with HIV-1 in which Vpx had been packaged (lower three panels), and the frequencies of infected (GFP+) CD71+ macrophages and CD71 monocytes were
determined by FACS. Upper three panels depict uninfected controls.
(D) The frequency of HIV-1 infection in CD71+ and CD71 cells at different intervals postinfection.to transduce nondividing cells (reviewed in Yamashita and Emer-
man, 2006). However, we observed that MLV infection of artifi-
cially growth-arrested HeLa cells was blocked at the level of
integration and not viral cDNA synthesis or nuclear import of viral
cDNA. This block was mechanistically distinct from the block we
observed in natural nondividingmacrophages, whereMLV trans-
duction was inhibited either prior to or at the level of reverse76 Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc.transcription of viral cDNA. When the block to reverse transcrip-
tion in macrophages was alleviated by Vpx, MLV integration and
gene expression occurred. Therefore, the differential ability of
lentiviruses and gammaretroviruses to transduce nondividing
macrophages is dictated by the degree to which they are sensi-
tive to a restriction that acts prior to or at the level of reverse
transcription.
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restrict gammaretrovirus infection of nondividing myeloid cells,
there still remains the question as to how viral genomes access
the nuclear compartment. Packaging of VpxwithinMLV particles
removed a block to reverse transcription and was sufficient to
permit transduction of terminally differentiated macrophages.
This indicates that if conditions for viral cDNA synthesis are
met, subsequent events including synthesis, nuclear import
and integration of viral cDNA, and de novo gene expression
occur in nondividing macrophages following both HIV-1 and
MLV infection. Therefore, presumably, the ability to traverse
the nuclear envelope appears to be an intrinsic property of gam-
maretroviruses and lentiviruses. Models invoking a nuclear
import role for Vpr/Vpx proteins have been supported by the
fact that these proteins exhibit a nuclear localization (reviewed
in Yamashita and Emerman, 2006). While our data argue against
the possibility that nuclear access is blocked during MLV infec-
tion of nondividing macrophages, it is possible that the restric-
tion is located in the nucleus and that Vpx must localize to the
nucleus in order to counteract the restriction.
We previously demonstrated (Sharova et al., 2008) that infec-
tion of macrophages by HIV-1 is influenced by a restriction and
that this restriction is sensitive to neutralization by Vpx, but not
SIVsmm Vpr or HIV-1 Vpr. Here, we demonstrate that Vpx but
not Vpr alleles of primate lentiviruses enhance infection of
macrophages by MLV. All primate lentiviruses encode a Vpr
protein. The Vpx gene of the HIV-2 group, which includes
HIV-2, SIVsmm, and SIVmac, arose by duplication of the Vpr
gene within this group (Sharp et al., 1996; Tristem et al., 1992),
which diverged from the other primate lentiviral groups around
200 years ago (Tristemet al., 1992).WhileVpx represents a dupli-
cation, it does not share all the functional properties of Vpr. Vpr
induces cell cycle arrest, whereas Vpx does not (Fletcher et al.,
1996). Conversely, the ability to neutralize a restriction inmyeloid
cells is governed by Vpx but not Vpr. Presumably, this activity
wasmanifest in the ancestral Vpr gene, but for unknown reasons
has been lost in the HIV-1 and SIVagm groups. It is possible that
loss in the ability to counteract the myeloid cell restriction was
compensated for by acquisition of partial resistance to the
restriction, as in the case of HIV-1.
Our studies further implicate a restriction as the obstacle to
infection of quiescent monocytes by lentiviruses. It is likely that
this same restriction antagonizes HIV-1 infection in monocytes
and in macrophages. However, the degree to which HIV-1 is
restricted in monocytes and macrophages differs considerably.
In the absence of Vpx, HIV-1 still has the ability to transduce
macrophages to some degree. Nevertheless, the efficiency
with which HIV-1 transduces macrophages is greatly increased
by Vpx. Therefore, while infection of macrophages by HIV-1 is
antagonized by a restriction, this restriction is not sufficient
to completely block transduction of these cells by HIV-1.
In contrast, monocytes are totally refractory to HIV-1 infection
in the absence of Vpx. Therefore, monocytes can be considered
fully nonpermissive and macrophages semipermissive to HIV-1
transduction. The extent to which monocytes and macrophages
are permissive to infection may relate to the levels at which the
restriction is expressed in these cells. A similar situation is
seen with APOBEC3G, in that some cell lines are semipermissive
with regards to Vif-deleted virus (Sheehy et al., 2002).While the restriction that is counteracted by Vpx is as yet
unidentified, it exhibits unique characteristics when compared
to other known antiviral restrictions. Viral Vif and Vpu proteins
that neutralize the antiviral restrictions APOBEC3G and teth-
erin/BST2, respectively, carry out their function in the virus-
producing cell (reviewed in Malim and Emerman, 2008).
Although some Vif is packaged within virions, there is no
evidence that packaged Vif has a functional role in viral infection.
By comparison, the ability of Vpx to neutralize the myeloid cell
restriction appears to require that it is packaged within virions.
Indeed, Vpx protein that was packaged into virions effected
a durable removal of the block to subsequent infection by a
restricted virus. This suggests that the restriction has an
extremely low turnover rate and takes a considerable time to
recover after it has been neutralized by Vpx.
Our study underscores the powerful degree to which restric-
tions shape lentivirus biology. Primate lentiviruses exhibit
tropism for macrophage lineage cells, and reservoirs of tissue
macrophages are evident in the gut, lung, lymph nodes, and
CNS (reviewed in Gonza´lez-Scarano and Martı´n-Garcı´a, 2005).
Tropism is dictated primarily by the expression of specific core-
ceptor molecules (mainly CCR5) on macrophages that permit
virus binding and entry (reviewed in Gorry et al., 2005). Our study
reveals a second level of tropism that is manifest postentry, and
our findings would suggest that the ability of primate lentiviruses
and perhaps nonprimate lentiviruses as well to establish reser-
voirs in myeloid lineage cells is dependent upon their ability to
counteract a myeloid cell-specific restriction. Given the potency
with which the restriction antagonizes primate lentivirus infec-
tion, identification of the restriction itself as well as pharmaco-




The retroviral delivery vector pLEGFP-C1 contains MLV-derived retroviral
elements along with a CMV promoter-driven EGFP gene (Clontech; Mountain
View, CA). Pseudotyping MLV and HIV-1 with VSV-G envelope involved
cotransfection with a VSV-G expression plasmid, pMD-G (Naldini et al.,
1996). pNL4-3.GFP contains the HIV-1 molecular clone NL4-3 with GFP in
place of nef. pNL4-3.Luc plasmid contains luciferase reporter gene in place
of envelope. The EGFP cassette in the expression vector pLEGFP-C1 was
swapped with dsRed to obtain MLV with dsRed reporter expression
(pLdsRed). The SIV clones were derived from SIVPBj (Fletcher et al., 1996).
pMLV-Gagp6 was generated by replacing the RFP cassette in pMLV-Gag-
RFP (Addgene plasmid 1814 obtained from Dr. W. Mothes [Sherer et al.,
2003]) with p6 amplified from SIVsmm. The Vpx expression vector has been
described previously (Sharova et al., 2008).
Cells and Viruses
Human monocytes were obtained from healthy donors by countercurrent
centrifugal elutriation (Gendelman et al., 1988). 293T and HeLa cells were
maintained in DMEM containing 10% FBS. PseudotypedMLV (MLV-G) stocks
were obtained by transfecting retroviral-packaging 293A cells with pLEGFP-C1
and pMD-G. Virus particles in culture supernatants were harvested after 24
and 48 hr, passed through 0.45 mm filter, and concentrated by ultracentrifuga-
tion. Vpx was packaged in MLV by cotransfecting 293A cells with pMD-G,
pLdsRed, pMLV-Gagp6, and Vpx expression vectors. Control virus was
made with the same plasmids, excluding MLV-Gagp6. Similarly, VSV-G-pseu-
dotyped HIV-1 (HIV-G) was prepared by transfecting 293T cells with pNL4-3.
GFP and pMD-G. The viruseswere titered by transducingHeLa or TZM-bl cells
with increasing virus inputs followed by flow cytometry analysis of GFP+ cells.Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc. 77
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culture supernatant that generated 50% GFP+ HeLa cells after 48 hr postin-
fection. Pseudotyped SIVsmm viruses were obtained by transfecting 293T
cells with a PBj1.9 molecular clone with (SIVWT) or without (SIVDVpx) Vpx
(Fletcher et al., 1996) along with pMD-G. All virus stocks were treated with
DNaseI (Worthington Biochemical Corporation; Lakewood, NJ) to remove
residual transfection DNA. In all experiments, the SIVsmm-PBj strain has
been used, unless specified otherwise.
Infection Assays
HeLa cells as well as macrophages were infected with increasing virus inputs
(TCID50) ofHIV1-GandMLV-G. After 4 hr, cellswerewashedwith freshmedium
and incubated at 37C for the remainder of the experiment. Preinfection studies
were performed by first infecting macrophages with pseudotyped SIVWT or
SIVDVpx variants, and 4 hr later, the cells were infected with MLV-G (four
TCID50) for another 4 hr before washing cells with fresh medium. After 42–72
hr, the numbers of GFP/dsRed cells were quantitated by flow cytometry.
Analysis of Viral Infection by Quantitative PCR
Infected cells were washed with PBS before harvesting samples for DNA anal-
ysis. Total DNA was extracted from infected cells by a DNeasy kit (QIAGEN).
Quantitative analysis of MLV cDNA intermediates is as described (Bruce
et al., 2005). PCR primers and probes for MLV include primers OJWB45 and
OJWB48 for late MLV transcripts, OJWB45 and OJWB46 for 2-LTR cDNA,
andMLV prb for cDNA detection (Bruce et al., 2005). PCR conditions for ampli-
fication of SIV and HIV-1 cDNAs are as described previously (Sharova et al.,
2008). Copy number estimates of cDNA and 2-LTR circles were determined
on an ABI Prism 7500 fast machine. Integrants were quantitated by Alu-LTR
real-time PCR as described by Brussel and Sonigo (Brussel and Sonigo,
2003). Briefly, PCR was first done for 12 cycles using Alu primers and
LTR-specific primer tagged with lambda sequence. The PCR product was
then diluted 10-fold and was used as a template for a quantitative nested
PCR using lambda primer and an LTR-specific reverse primer. The number
of cell equivalents in DNA lysates from HeLa cells, monocytes, macrophages,
and heterokaryons was determined by PCR using CCR5-specific primers (Hat-
zakis et al., 2000). The real-time PCR analysis from each sample was carried
out in duplicate wells, andmost of the values shown in the figures are averages
of independent experiments using macrophages from at least three different
donors.
APOBEC3G Analysis
H9 cells, monocytes, or macrophages were washed twice with PBS and incu-
bated with lysis buffer containing 50 mMHEPES (pH 7.4), 125 mMNaCl, 0.2%
NP-40, and EDTA-free protease inhibitor cocktail (Roche). Cell lysates were
clarified by centrifugation at 14,000 rpm for 30 min at 4C (Microfuge 22R,
Beckman Coulter). Cleared cell lysates were quantitated (Bio-Rad Protein
Assay Kit) and analyzed by Fast Performance Liquid Chromatography
(FPLC). For RNase treatment of HMM complexes from H9 cells, cell lysates
were incubated with 50 mg/ml RNase A (DNase-free, Roche) at room temper-
ature for 1 hr before analysis by FPLC. FPLC was run on an A¨KTA FPLC using
a Superose 6 10/300 GL gel filtration column (GE Healthcare). The running
buffer contained 50 mM HEPES (pH 7.4), 125 mM NaCl, 0.1% NP-40, 1 mM
DTT, and 10% glycerol. Fraction size was set at 1 ml. Twenty microliters of
each fraction was boiled with Laemmli buffer (63 reducing, Boston BioProd-
ucts, Inc.; Worcester, MA) and loaded onto a 10% SDS-PAGE. Proteins
were transferred to nitrocellulose membranes and blotted with rabbit anti-
APOBEC3G antibody (courtesy of Dr. Tariq Rana) using a Tropix CDP-Star
system (PerkinElmer; Waltham, MA).
FACS and Macrophage Immunophenotyping
Expression of CD14, CD71, or GFP/dsRed in monocytes/macrophages was
monitored by flow cytometry. Cells were collected from day 0 to day 6 postin-
fection and washed twice with buffer (PBS containing 0.1% FBS and 2 mM
EDTA). The washed cells were incubated with an antibody mixture containing
PE-conjugated anti-human CD14 (BD Biosciences) and APC-conjugated anti-
human CD71 (BD Biosciences) for 40 min. Cells were rinsed twice with
washing buffer and fixed with 1% paraformaldehyde. Fixed cells were
analyzed by cell flow cytometry analysis using a FACSCalibur System (BD78 Cell Host & Microbe 6, 68–80, July 23, 2009 ª2009 Elsevier Inc.Biosciences) and analyzed with FlowJo software (Tree Star, Inc.; Ashland,
OR). The percentages of infected CD71monocytes andCD71+macrophages
were determined from the percentages of GFP+/CD71 or GFP+/CD71+ cells,
respectively.
Cell Fusion
HeLa-macrophage fusion was achieved using paramyxovirus hemagglutinin-
neuraminidase (HN) protein and fusion (F) proteins as described (Sharova
et al., 2008). Briefly, HeLa cells were transfected with pCAGGS-HN and
pCAGGS-F expression vectors encoding HN and F proteins of NDV. Sixteen
hours posttransfection, HeLa cells were stained with 1.7 mM DiO, mixed with
macrophages stained with 0.85 mM DiD (Molecular Probes) in a ratio of 1:2,
and plated in 100 mm dishes. After overnight incubation, cells were infected
withMLV for 40 hr. Cell sorting was performed with a FACSAria flow cytometer
using the FACSDiva software (Becton Dickinson). Double-stained cells were
sorted, and total DNA was isolated using a DNeasy Blood and Tissue Kit
(QIAGEN) and analyzed by real-time PCR assay for late MLV cDNA and
2-LTR circles. HeLa-monocyte fusion was achieved using a GenomeONE-
CFEX HVJ Envelope Cell Fusion kit (Cosmo Bio Co., Ltd.; Tokyo). Manufac-
turer’s instructions for fusion in suspension were followed. Briefly, GFP-
expressing HeLa were mixed with monocytes (ratio 1:6) and incubated in the
presence of HVJ-E suspension (1.25 ml/1 3 106 cells) on ice for 5 min and
subsequently at 37C for 15 min. Cells were plated in 100 mm dishes and
infected with HIV-1 NL4-3.Luc or SIVWT for 40 hr. Prior to cell sorting, cells
were stained with an APC-conjugated antibody to CD14 (BD Biosciences).
Heterokaryons were sorted based on GFP and APC double staining. HIV-1
NL4-3.Luc infection was measured by quantifying luciferase activity, and
SIVWT infection was analyzed by real-time PCR assay for late cDNA and
2-LTR circles.
SUPPLEMENTAL DATA
Supplemental Data include two figures and can be found online at http://www.
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